Tissue Sealants Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4000
Buy Report View Sample

Published: June 24, 2022 Report Code: GDME1391EPD-ST

Select Item

The tissue sealant pipeline product market research report provides comprehensive information about the pipeline products with comparative analysis at various stages of development and information about the clinical trials which are in progress. It also gives review details of major pipeline products including product description, licensing and collaboration details, and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates.

Which are the key categories in the tissue sealant pipeline product market?

The key categories in the tissue sealant pipeline product market are Synthetic Tissue Sealants, Fibrin Based Tissue Sealants, Fibrin Based Tissue Sealants in Liquid Form, and Other Protein-Based Tissue Sealants. Synthetic Tissue Sealants has the highest number of pipeline products.

Tissue sealant pipeline product market, by category

Tissue sealant pipeline product market, by category

For more category insights, download a free report sample

Which are the key territories in the tissue sealant pipeline product market?

The key territories in the tissue sealant pipeline product market are the United States, Europe, Israel, Italy, South Korea, the United Kingdom, Brazil, Canada, China, and Japan. The US has the highest number of pipeline products.

Tissue sealant pipeline product market, by territories

Tissue sealant pipeline product market, by territories

For more territory insights, download a free report sample

Which are the key regulatory paths in the tissue sealant pipeline product market?

The key regulatory paths in the tissue sealant pipeline product market are 510(k), PMA, CE, MDITAC, MDL, Ninsho, NMPA, and ANVISA. 510(k) has the highest number of pipeline products.

Tissue sealant pipeline product market, by regulatory path

Tissue sealant pipeline product market, by regulatory path

For more regulatory path insights, download a free report sample

Which are the key companies in the tissue sealant pipeline product market?

The key companies in the tissue sealant pipeline product market are Adhesys Medical GmbH, Advanced Medical Solutions Group plc, Aleo BME Inc, Angiotech Pharmaceuticals Inc, Arch Therapeutics Inc, Arizona State University, Baxter International Inc, Biomedica Management Corp, and Boston University.

Market report overview

Key categories Synthetic Tissue Sealants, Fibrin Based Tissue Sealants, Fibrin Based Tissue Sealants in Liquid Form, and Other Protein-Based Tissue Sealants
Key territories The United States, Europe, Israel, Italy, South Korea, the United Kingdom, Brazil, Canada, China, and Japan
Key regulatory paths 510(k), PMA, CE, MDITAC, MDL, Ninsho, NMPA, and ANVISA
Key companies Adhesys Medical GmbH, Advanced Medical Solutions Group plc, Aleo BME Inc, Angiotech Pharmaceuticals Inc, Arch Therapeutics Inc, Arizona State University, Baxter International Inc, Biomedica Management Corp, and Boston University

 Scope

  • Extensive coverage of the Tissue Sealants under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Tissue Sealants and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies

  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

  • Identify and understand important and diverse types of Tissue Sealants under development

  • Develop market-entry and market expansion strategies

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Adhesys Medical GmbH
Advanced Medical Solutions Group plc
Aleo BME Inc
Angiotech Pharmaceuticals Inc
Arch Therapeutics Inc
Arizona State University
Baxter International Inc
Biomedica Management Corp
Boston University
Calmare Therapeutics Inc
Clemson University
Cohera Medical Inc
Covalent Medical, Inc. (Inactive)
CR Bard Inc
DSM Biomedical BV
Eidgenossische Materialprufungs- und Forschungsanstalt
Elastagen Pty Ltd
Ethicon Endo-Surgery Inc
Gamma Therapeutics Inc
GATT Technologies BV
Hemostasis LLC
HyperBranch Medical Technology Inc
Institute of Molecular Biology of Parana
InVivo Therapeutics Corp
Johns Hopkins University
Kollodis BioSciences Inc
Kuros Biosciences AG
Laser Tissue Welding, Inc.
Medisse BV (Inactive)
Meril Life Sciences Pvt Ltd
Nurami Medical Ltd
Pharming Group NV
Polyganics BV
Protein Polymer Technologies Inc (Inactive)
Purdue University
Samyang Biopharmaceuticals Corp
Sealantis Ltd.
Shanghai Haohai Biological Technology Co Ltd
Surgical Sealants, Inc.
Teijin Pharma Ltd
Texas A&M University
The Medicines Co
Tissium SA
University of Akron

Table of Contents

1 Table of Contents 3

|1.1 List of Tables 7

|1.2 List of Figures 11

2 Introduction 12

2.1 Tissue Sealants Overview 12

3 Products under Development 13

3.1 Tissue Sealants – Pipeline Products by Stage of Development 13

3.2 Tissue Sealants – Pipeline Products by Segment 14

3.3 Tissue Sealants – Pipeline Products by Territory 15

3.4 Tissue Sealants – Pipeline Products by Regulatory Path 16

3.5 Tissue Sealants – Pipeline Products by Estimated Approval Date 17

3.6 Tissue Sealants – Ongoing Clinical Trials 18

4 Tissue Sealants – Pipeline Products under Development by Companies 19

4.1 Tissue Sealants Companies – Pipeline Products by Stage of Development 19

4.2 Tissue Sealants – Pipeline Products by Stage of Development 21

5 Tissue Sealants Companies and Product Overview 23

5.1 Adhesys Medical GmbH Company Overview 23

5.1.1 Adhesys Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview 23

5.2 Advanced Medical Solutions Group plc Company Overview 24

5.2.1 Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview 24

5.3 Aleo BME Inc Company Overview 25

5.3.1 Aleo BME Inc Pipeline Products & Ongoing Clinical Trials Overview 25

5.4 Angiotech Pharmaceuticals Inc Company Overview 27

5.4.1 Angiotech Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 27

5.5 Arch Therapeutics Inc Company Overview 28

5.5.1 Arch Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 28

5.6 Arizona State University Company Overview 29

5.6.1 Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 29

5.7 Baxter International Inc Company Overview 30

5.7.1 Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 30

5.8 Biomedica Management Corp Company Overview 31

5.8.1 Biomedica Management Corp Pipeline Products & Ongoing Clinical Trials Overview 31

5.9 Boston University Company Overview 32

5.9.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 32

5.10 Calmare Therapeutics Inc Company Overview 33

5.10.1 Calmare Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 33

5.11 Clemson University Company Overview 34

5.11.1 Clemson University Pipeline Products & Ongoing Clinical Trials Overview 34

5.12 Cohera Medical Inc Company Overview 35

5.12.1 Cohera Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 35

5.13 Covalent Medical, Inc. (Inactive) Company Overview 38

5.13.1 Covalent Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 38

5.14 CR Bard Inc Company Overview 39

5.14.1 CR Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 39

5.15 Department of Biomedical Engineering Columbia University Company Overview 42

5.15.1 Department of Biomedical Engineering Columbia University Pipeline Products & Ongoing Clinical Trials Overview 42

5.16 DSM Biomedical BV Company Overview 43

5.16.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 43

5.17 Eidgenossische Materialprufungs- und Forschungsanstalt Company Overview 44

5.17.1 Eidgenossische Materialprufungs- und Forschungsanstalt Pipeline Products & Ongoing Clinical Trials Overview 44

5.18 Elastagen Pty Ltd Company Overview 45

5.18.1 Elastagen Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 45

5.19 Ethicon Endo-Surgery Inc Company Overview 46

5.19.1 Ethicon Endo-Surgery Inc Pipeline Products & Ongoing Clinical Trials Overview 46

5.20 Gamma Diagnostics Inc Company Overview 47

5.20.1 Gamma Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 47

5.21 GATT Technologies BV Company Overview 48

5.21.1 GATT Technologies BV Pipeline Products & Ongoing Clinical Trials Overview 48

5.22 Hemostasis LLC Company Overview 50

5.22.1 Hemostasis LLC Pipeline Products & Ongoing Clinical Trials Overview 50

5.23 HyperBranch Medical Technology Inc Company Overview 51

5.23.1 HyperBranch Medical Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 51

5.24 Institute of Molecular Biology of Parana Company Overview 53

5.24.1 Institute of Molecular Biology of Parana Pipeline Products & Ongoing Clinical Trials Overview 53

5.25 InVivo Therapeutics Corp Company Overview 54

5.25.1 InVivo Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview 54

5.26 Johns Hopkins University Company Overview 55

5.26.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 55

5.27 Kollodis BioSciences Inc Company Overview 56

5.27.1 Kollodis BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview 56

5.28 Kuros Biosciences AG Company Overview 57

5.28.1 Kuros Biosciences AG Pipeline Products & Ongoing Clinical Trials Overview 57

5.29 Laser Tissue Welding, Inc. Company Overview 59

5.29.1 Laser Tissue Welding, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59

5.30 Medisse BV (Inactive) Company Overview 60

5.30.1 Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 60

5.31 Meril Life Sciences Pvt Ltd Company Overview 61

5.31.1 Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 61

5.32 Nurami Medical Ltd Company Overview 62

5.32.1 Nurami Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 62

5.33 Pharming Group NV Company Overview 63

5.33.1 Pharming Group NV Pipeline Products & Ongoing Clinical Trials Overview 63

5.34 Polyganics BV Company Overview 64

5.34.1 Polyganics BV Pipeline Products & Ongoing Clinical Trials Overview 64

5.35 Protein Polymer Technologies Inc (Inactive) Company Overview 70

5.35.1 Protein Polymer Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 70

5.36 Purdue University Company Overview 71

5.36.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 71

5.37 Samyang Biopharmaceuticals Corp Company Overview 72

5.37.1 Samyang Biopharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview 72

5.38 Sea Run Holdings Inc Company Overview 73

5.38.1 Sea Run Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 73

5.39 Sealantis Ltd. Company Overview 74

5.39.1 Sealantis Ltd. Pipeline Products & Ongoing Clinical Trials Overview 74

5.40 Shanghai Haohai Biological Technology Co Ltd Company Overview 80

5.40.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 80

5.41 Surgical Sealants, Inc. Company Overview 81

5.41.1 Surgical Sealants, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81

5.42 Teijin Pharma Ltd Company Overview 82

5.42.1 Teijin Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview 82

5.43 Texas A&M University Company Overview 83

5.43.1 Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview 83

5.44 The Medicines Co Company Overview 85

5.44.1 The Medicines Co Pipeline Products & Ongoing Clinical Trials Overview 85

5.45 Tissium SA Company Overview 86

5.45.1 Tissium SA Pipeline Products & Ongoing Clinical Trials Overview 86

5.46 University of Akron Company Overview 89

5.46.1 University of Akron Pipeline Products & Ongoing Clinical Trials Overview 89

6 Tissue Sealants- Recent Developments 90

6.1 Jun 08, 2022: Baxter to Host Second-Quarter 2022 Financial Results Conference Call for Investors 90

6.2 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results 90

6.3 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase 90

6.4 May 25, 2022: Baxter Highlights Business Strategies and Innovation at 2022 Investor Conference 90

6.5 May 19, 2022: ThermoGenesis Holdings Announces Financial Results for the First Quarter Ended March 31, 2022 and Provides Corporate Update 91

6.6 May 16, 2022: Analysts Anticipate Artivion to Announce $0.09 Earnings Per Share 92

6.7 May 12, 2022: Johnson & Johnson to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference 92

6.8 May 11, 2022: Johnson & Johnson Appoints Thibaut Mongon as CEO Designate of Planned New Consumer Health Company 92

6.9 May 10, 2022: Johnson & Johnson MedTech Adds New CFO to the Mix 93

6.10 May 10, 2022: Baxter to Host 2022 Investor Conference 93

6.11 May 02, 2022: Johnson & Johnson to Participate in the Bernstein 38th Annual Strategic Decisions Conference 93

6.12 Apr 21, 2022: Artivion Announces Release Date and Teleconference Call Details for First Quarter 2022 Financial Results 94

6.13 Apr 20, 2022: Johnson & Johnson to Participate in the UBS Global Healthcare Conference 94

6.14 Apr 19, 2022: Johnson & Johnson Reports Q1 2022 Results 94

6.15 Apr 07, 2022: Johnson & Johnson to Participate in the BofA Securities 2022 Healthcare Conference 95

6.16 Mar 28, 2022: ThermoGenesis Holdings Announces Year End 2021 Financial Results and Provides Corporate Update 95

6.17 Mar 28, 2022: Leading medical device company to build Center for Excellence in Cellular Manufacturing in Greater Sacramento (Rancho Cordova) 97

6.18 Mar 15, 2022: Johnson & Johnson to Host Investor Conference Call on First-Quarter Results 98

6.19 Mar 09, 2022: Artivion to Host Investor & Analyst Day on March 23, 2022 98

6.20 Feb 22, 2022: Asahi Kasai Names Company Veteran as New President 99

6.21 Feb 15, 2022: Johnson & Johnson Names Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, to its Board of Directors 99

6.22 Feb 10, 2022: Baxter to Present at Citi’s 2022 Virtual Healthcare Conference 99

6.23 Feb 09, 2022: Johnson & Johnson to Participate in the Raymond James 43rd Annual Institutional Investors Conference 99

6.24 Feb 07, 2022: Johnson & Johnson to Participate in the Cowen 42nd Annual Health Care Virtual Conference 100

6.25 Jan 27, 2022: Johnson & Johnson to Participate in Citi’s 2022 Virtual Healthcare Conference 100

6.26 Jan 25, 2022: Johnson & Johnson Reports Q4 and Full-Year 2021 Results 100

6.27 Jan 06, 2022: Baxter to Host Fourth-Quarter 2021 Financial Results Conference Call for Investors 101

6.28 Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference 101

6.29 Dec 10, 2021: Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results 101

6.30 Dec 08, 2021: Johnson & Johnson to Participate in the 40th Annual J.P. Morgan Healthcare Conference 102

6.31 Nov 12, 2021: ThermoGenesis Holdings Announces Financial Results for the Third Quarter Ended September 30, 2021, and Provides Corporate Update 102

6.32 Nov 05, 2021: ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2021 and Provide a Corporate Strategic Update 103

6.33 Nov 02, 2021: Baxter to Present at Evercore ISI 4th Annual HealthCONx Conference 104

6.34 Oct 13, 2021: Baxter to Present at Credit Suisse 30th Annual Virtual Healthcare Conference 104

6.35 Oct 12, 2021: Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson To Retire, Effective December 31, 2021 104

6.36 Oct 12, 2021: Johnson & Johnson Announces Jessica Moore as Vice President of Investor Relations 105

6.37 Oct 11, 2021: Johnson & Johnson to Participate in the Credit Suisse 30th Annual Healthcare Conference 106

6.38 Sep 27, 2021: Baxter to Host Third-Quarter 2021 Financial Results Conference Call for Investors 106

6.39 Sep 22, 2021: Anthony Semedo Joins CryoLife Board of Directors 106

6.40 Sep 16, 2021: Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results 107

6.41 Sep 09, 2021: InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright Annual Global Investment Conference 107

6.42 Aug 19, 2021: Alex Gorsky to Serve as Executive Chairman and Transition Role of Chief Executive Officer of Johnson & Johnson to Joaquin Duato, Effective January 3, 2022 107

6.43 Aug 12, 2021: Johnson & Johnson to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference 110

6.44 Aug 12, 2021: ThermoGenesis Holdings Announces Financial Results for the Second Quarter Ended June 30, 2021, and Provides Corporate Update 110

6.45 Aug 09, 2021: Johnson & Johnson to Participate in Barclays Global Consumer Staples Virtual Conference 111

6.46 Aug 05, 2021: ThermoGenesis Holdings to Announce Financial Results for the Second Quarter Ended June 30, 2021 and Provide a Corporate Strategic Update 112

6.47 Jul 30, 2021: Grifols signs an agreement with ImmunoTek to open 21 plasma centers and further advances on its expansion plan 112

6.48 Jul 29, 2021: Baxter Reports Second-Quarter 2021 Results 113

6.49 Jul 29, 2021: Baxter to Present at UBS Genomics

2.0 and MedTech Innovations Summit 115

6.50 Jul 29, 2021: CryoLife Reports Second Quarter 2021 Financial Results 115

6.51 Jul 27, 2021: Johnson & Johnson to Participate in the Virtual Wells Fargo Healthcare Conference 116

6.52 Jul 21, 2021: Johnson & Johnson Reports 2021 Second-Quarter Results 116

6.53 Jul 15, 2021: CryoLife Announces Release Date and Teleconference Call Details for Second Quarter 2021 Financial Results 117

6.54 Jul 07, 2021: Advanced Medical Solutions Group: Half year trading update 117

6.55 Jun 30, 2021: Asahi Kasei Announces Q1 2021 Financial Results 118

7 Appendix 119

7.1 Methodology 119

7.2 About GlobalData 121

7.3 Contact Us 122

7.4 Disclaimer 122

Frequently asked questions

Tissue Sealants Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

Most Popular
$8,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Tissue Sealants Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Wound Care Management reports
Medical Devices
United States Surgical Energy Instruments Market Size (Value, Volume, ASP)…
$500 | December 2021
Medical Devices
Argentina Surgical Energy Instruments Market Size (Value, Volume, ASP) by…
$500 | December 2021
Medical Devices
Brazil Surgical Energy Instruments Market Size (Value, Volume, ASP) by…
$500 | December 2021
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Tissue Sealants Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update in real time.

  • Access a live Tissue Sealants Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more